She studied Biology at the University of Regensburg, Germany and the University of Boulder, CO, USA focusing on Genetics, Developmental Biology and Medical Microbiology. Also a contract Professor at the Department of Public Health of the University of Genoa, Italy, he has made significant contributions to the organization and implementation of a Master in Vaccinology and Pharmaceutical Clinical Development for MDs from developing countries in collaboration with the University of Siena, where he obtained his medical degree and subsequently a specialization in Pediatric Infectious Diseases.īirgit Weinberger, PhD, Professor Professor of immunology division Institute for Biomedical Aging Research Innsbruck, Austriaīirgit Weinberger is Professor of immunology division Institute for Biomedical Aging Research Innsbruck, Austria.
Anemona srl registration#
In the last 20 years, he has led various vaccine development programs resulting in the clinical testingand registration worldwide of several novel vaccine candidates. He was previously Vice-President and Global Head of Clinical Research Development and Medical Affairs and subsequently of Global Regulatory Affairs at Novartis Vaccines. Audino Podda is Head, Clinical Development & Regulatory Affairs at Sclavo Behring Vaccines Institute For Global Health S.r.l., (formerly NVGH). He worked as an infectious disease epidemiologist at Rhode Island State Department of Health, US, for two years, before joining the Bill and Melinda Gates Foundation.Īnanda is a guest lecturer for advanced degree programs in public health and infectious diseases in several globally renowned teaching venues including the Harvard University.Īudino Podda, MD, Professor Head Clinical Development & Regulatory Affairs GSK Vaccine Institute for Global Health, Siena, Italyĭr.
In between he worked for the polio eradication initiative in five states in India as a Surveillance Medical Officer for polio and measles with WHO and contributed to the successful and historic polio eradication effort and measles surveillance initiatives in India. He received his Master of Public Health degree in Global Health from Harvard School of Public Health in 2010.
He grew up in India and qualified for his medical degree from the Calcutta National Medical College & Hospital in 2005. He also organized the Profesional Master Course Degree at Bio-Manguinhos.Īnanda Bandyopadhyay, MD, MPH Senior Program Officer, Polio Research Bill & Melinda Gates Foundation, USAĪnanda Bandyopadhyay is since 2012 Senior Program Officer at the Bill & Melinda Gates Foundation in Seattle, USA with responsibility to support global polio vaccine research and product development across multiple countries and geographies, including South Asia, Latin America, Africa and Europe. Homma was responsible to the activities related to the technology development of immunebiologicals and manufacturing activities at industrial scale, which was initiated in 1976 with only one product and 26 employees, and he left the direction with a portfolio of 17 products and 1.200 employees. As Director of Bio-Manguinhos - 20 years in two terms - Dr. Akira Homma is a Medical-Veterinary graduate of Faculty of Veterinary Medicine, Universidade Federal Niterói, Brazil.
Anemona srl professional#
The Political and Strategic Council features among its professional members recognized by the developed works and linked to important institutions related to Bio-Manguinhos activities and also representative of the society as a whole, as the Department of Science and Technology of the Ministry of Health, BNDES (The Brazilian Development Bank), ABIFINA (Brazilian Association of Fine Chemistry Industries, Biotechnology and its Specialties), Butantan Institute, as well as elected representatives of the community. Akira Homma, MD president of the Political and Strategic Council (PSC) of Bio-Manguinhos Oswaldo Cruz Foundation (Fiocruz)Īkira Homma is the president of the Political and Strategic Council (PSC) of Bio-Manguinhos of the Oswaldo Cruz Foundation (Fiocruz) based in Brazil.
0 kommentar(er)
